AC Immune (ACIU) EBIT Margin (2015 - 2026)

AC Immune's (ACIU) quarterly EBIT Margin came in at 1321.54% in Q1 2026, up 63503.0% year-on-year from N/an in Q1 2025, and up 68.97% on a QoQ basis from 4258.58% in Q4 2025.

AC Immune (ACIU) EBIT Margin (2015 - 2026) Analysis & Trends

AC Immune (ACIU) has 10 years of EBIT Margin data on file, last reported at 1321.54% in Q1 2026.

  • On a quarterly basis, EBIT Margin rose 63503.0% year-over-year to 1321.54% in Q1 2026; TTM through Mar 2026 was 1749.24%, a 157246.0% decrease from a year earlier, with the FY2025 full-year figure at 1940.05%, down 174825.0% from the prior year.
  • EBIT Margin for Q1 2026 stood at 1321.54%, up from 4258.58% in the prior quarter.
  • Over the last five years, EBIT Margin for ACIU reached as high as 28.52% in Q3 2024 and fell as low as 4258.58% in Q4 2025.
  • Historically, EBIT Margin has averaged 1749.79% across 4 years, with a median of 1637.47% in 2024.
  • On a YoY basis, EBIT Margin climbed as much as 156656 bps in 2025 and fell as far as 262111 bps in 2025.
  • Year by year, EBIT Margin stood at 345.21% in 2022, then plunged by 374 bps to 1637.47% in 2024, then slumped by 160 bps to 4258.58% in 2025, then surged by 69 bps to 1321.54% in 2026.
  • Per Business Quant data, the three most recent EBIT Margin figures were 1321.54% in Q1 2026, 4258.58% in Q4 2025, and 1721.62% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 16.51%
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 38.10%
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 17.83%
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 30.35%
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 AC Immune 222.66 Mn 222.66 Mn - -1,321.54%

Historic Data

Download Data
DateValue
Mar 31, 2026 -1,321.54%
Dec 31, 2025 -4,258.58%
Sep 30, 2025 -1,721.62%
Jun 30, 2025 -1,484.53%
Mar 31, 2025 -1,956.57%
Dec 31, 2024 -1,637.47%
Sep 30, 2024 28.52%
Jun 30, 2024 -3,051.09%
Sep 30, 2022 -345.21%
Dec 31, 2020 -2,061.97%
Sep 30, 2020 -1,674.53%
Jun 30, 2020 -1,448.48%
Mar 31, 2020 -59.46%
Dec 31, 2019 -2,188.72%
Sep 30, 2019 817.14%
Jun 30, 2019 -977.76%
Mar 31, 2019 80.16%
Dec 31, 2018 -1,292.42%
Sep 30, 2018 -528.03%
Jun 30, 2018 -570.51%